Cargando…
Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?
Autores principales: | Ya'Qoub, Lina, Mansoor, Hend, Elgendy, Islam Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547264/ https://www.ncbi.nlm.nih.gov/pubmed/37671619 http://dx.doi.org/10.1161/JAHA.123.031615 |
Ejemplares similares
-
Impact of COVID-19 on Management Strategies for Coronary and Structural Heart Disease Interventions
por: Ya’Qoub, Lina, et al.
Publicado: (2022) -
Sex and gender differences in COVID-19: More to be learned!()
por: Ya'qoub, Lina, et al.
Publicado: (2021) -
Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data
por: Lewek, Joanna, et al.
Publicado: (2023) -
Acute De Novo Multivessel Spontaneous Coronary Artery Dissection: A Case Report and Review of Literature
por: Ya’qoub, Lina, et al.
Publicado: (2019) -
Effects of Statin versus the Combination of Ezetimibe plus Statin on Serum Lipid Absorption Markers in Patients with Acute Coronary Syndrome
por: Watanabe, Erisa, et al.
Publicado: (2015)